In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates

The development of novel antibiotics is mandatory to curb the growing antibiotic resistance problem resulting in difficult-to-treat bacterial infections. Here, we have determined the spectrum of activity of cystobactamids and chelocardins, two novel and promising classes of molecules with different...

Descripción completa

Detalles Bibliográficos
Autores principales: Rima, Mariam, Pfennigwerth, Niels, Cremanns, Martina, Cirnski, Katarina, Oueslati, Saoussen, Gatermann, Sören G., d’Amélio, Nicola, Herrmann, Jennifer, Müller, Rolf, Naas, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451163/
https://www.ncbi.nlm.nih.gov/pubmed/37627685
http://dx.doi.org/10.3390/antibiotics12081265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10451163/
https://www.ncbi.nlm.nih.gov/pubmed/37627685
http://dx.doi.org/10.3390/antibiotics12081265

Ejemplares similares